Cargando…
MicroRNA as a Novel Biomarker in the Diagnosis of Head and Neck Cancer
Head and neck squamous cell carcinoma is the sixth most common cancer worldwide, with 890,000 new cases and 450,000 deaths in 2018, and although the survival statistics for some patient groups are improving, there is still an urgent need to find a fast and reliable biomarker that allows early diagno...
Autores principales: | Kabzinski, Jacek, Maczynska, Monika, Majsterek, Ireneusz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8228566/ https://www.ncbi.nlm.nih.gov/pubmed/34198889 http://dx.doi.org/10.3390/biom11060844 |
Ejemplares similares
-
RNA-Based Liquid Biopsy in Head and Neck Cancer
por: Kabzinski, Jacek, et al.
Publicado: (2023) -
ASSOCIATION OF BASE EXCISION REPAIR PATHWAY GENES OGG1, XRCC1 AND MUTYH POLYMORPHISMS AND THE LEVEL OF 8-OXO-GUANINE WITH INCREASED RISK OF COLORECTAL CANCER OCCURRENCE
por: Kabziński, Jacek, et al.
Publicado: (2022) -
The Role of the ER-Induced UPR Pathway and the Efficacy of Its Inhibitors and Inducers in the Inhibition of Tumor Progression
por: Walczak, Anna, et al.
Publicado: (2019) -
MicroRNA Profiling and Head and Neck Cancer
por: Liu, Xiqiang, et al.
Publicado: (2009) -
MicroRNA as a Novel Modulator in Head and Neck Squamous Carcinoma
por: Chen, Li-Hsin, et al.
Publicado: (2010)